This inventor holds 2 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 1 EPO patent. Top assignee: Future Medicine Co., Ltd.. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2024
Title: Hee Woo Lee: Innovator in Pharmaceutical Composition
Introduction
Hee Woo Lee is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at treating eye diseases. With a total of 2 patents, his work is paving the way for advancements in medical treatments.
Latest Patents
Lee's latest patents include a pharmaceutical composition for preventing and treating glaucoma, which contains an adenosine derivative. This composition is designed to prevent or treat eye diseases and includes an oral administration agent. The active ingredient in this pharmaceutical composition is represented by Chemical Formula 1 or a pharmaceutically acceptable salt thereof. His innovative approach addresses critical needs in ophthalmology.
Career Highlights
Hee Woo Lee is currently associated with Future Medicine Co., Ltd., where he continues to push the boundaries of pharmaceutical research. His work is characterized by a commitment to improving patient outcomes through innovative solutions.
Collaborations
Lee collaborates with talented individuals in his field, including Sang Koo Lee and Hea Ok Kim, who contribute to the research and development efforts at Future Medicine Co., Ltd.
Conclusion
Hee Woo Lee's contributions to pharmaceutical compositions demonstrate his dedication to advancing medical science. His innovative patents are crucial in the fight against eye diseases, showcasing the importance of research and collaboration in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile